Moderna, bird flu

Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine: HHS
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.
HHS invests nearly $600 million in Moderna’s bird flu vaccine development
The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect against bird flu, the pharmaceutical company announced Friday.
Moderna is a 'trade' on Bird Flu vaccine pop, says Mizuho's Jared Holz
Jared Holz, Mizuho Healthcare Sector strategist, joins 'Closing Bell Overtime' to talk Moderna and Novo Nordisk.
US awards Moderna $590 million for bird flu vaccine development
The U.S. government has awarded Moderna $590 million to advance the late-stage development of its mRNA bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans.
U.S. Gives Moderna $590 Million to Accelerate a Bird Flu Vaccine
The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
Moderna stock surges on bird flu vaccine funding
Shares of Moderna (NASDAQ:MRNA) jumped 5% following reports that it had been awarded $590 million for the development of a bird flu vaccine. The funding, provided by the Department of Health and Human Services,
MercoPress1d
COVID-19 booster shots are better if specific brands are used
researchers recommended that people who received it get a second booster dose with an mRNA vaccine such as Moderna and Pfizer. According to the published results, there were 129 coronavirus ...
justthenews11d
Moderna buried child's death in COVID booster trial in EU report, FDA response called 'misleading'
Stock-plunging mRNA vaccine maker, already in bed with feds on vaccine royalties, says booster not "causally" related without ...
Forbes3d
Moderna May Have The Best Shot At A Vaccine For Stomach Flu
There are currently three vaccine candidates moving through the clinical pipeline in human trials right now, and the furthest along is Moderna, which has developed a norovirus vaccine with the ...
Monthly Prescribing Reference3d
Moderna Provides Update on Norovirus Vaccine Candidate
Moderna’s mRNA-1403 is a messenger RNA-based trivalent vaccine candidate designed to protect against multiple norovirus genotypes. Moderna provided an update on the status of its trial investigating a ...
The Boston Globe4d
Moderna shares plunge after company cuts vaccine sales outlook
Moderna Inc. shares plunged after the company slashed its sales forecast for this year as it struggles with slow demand for its Covid and RSV vaccines. The Cambridge, Massachusetts-based company ...
Moderna shares slide as it slashes revenue forecast
Moderna slashed its 2025 revenue projection by $1bn on Monday, citing reduced demand for its Covid-19 and respiratory ...
Reuters5d
Moderna cuts 2025 sales forecast by $1 bln on weak vaccine demand, shares tumble
while adoption of its RSV shot - its second approved product- has been slower than expected, forcing Moderna to cut costs. "The bumpy ride gets bumpier," said Bernstein analyst Courtney Breen ...
FiercePharma4d
JPM25: Moderna slashes guidance, plots $1B in cost cuts this year amid lackluster vaccine sales
Stéphane Bancel, CEO of mRNA specialist Moderna, delivered some difficult truths to shareholders about the company’s ...